Aashima Gupta
About Aashima Gupta
Aashima Gupta (age 54) is a technology executive focused on healthcare AI and digital transformation; she joined Waystar’s Board in 2025 and was determined to be an independent director under Nasdaq rules. She serves as Global Director, Healthcare Solutions at Google Cloud (since Nov 2018), previously led digital transformation at Apigee (2015–2016) and digital health at Kaiser Permanente (2010–2015). Waystar expanded its Board to 12 directors in May 2025 and appointed Ms. Gupta thereafter; the company announced her appointment on June 16, 2025. Modern Healthcare named her one of the Top 10 Executives to Watch in 2024.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Google Cloud | Global Director, Healthcare Solutions | Nov 2018–present | Leads healthcare AI strategy and solutions. |
| Apigee (Google Cloud service) | VP – Digital Transformation – Healthcare | Jan 2015–Nov 2016 | Drove API-led digital healthcare initiatives. |
| Kaiser Permanente | Executive Director, Digital Health (technology development) | 2010–Jan 2015 | Digital health programs at scale. |
External Roles
| Organization | Role | Type | Start |
|---|---|---|---|
| Neogen | Director | Public company | 2022 |
| Mölnlycke Health Care | Director | Private company | Not disclosed |
| HIMSS | Global Health Advisory Board member | Non-profit | Not disclosed |
Recognition: Modern Healthcare “Top 10 Executives to Watch” (2024).
Board Governance
- Independent director; appointed as a Class III director following board expansion and deemed independent under Nasdaq and company guidelines.
- Committee assignment: Audit & Risk Committee.
- Board expansion from 10 to 12 directors recommended May 9, 2025; Gupta’s and Roman’s appointments contingent on certificate amendment effectiveness.
- No related-party transactions for Ms. Gupta requiring Item 404(a) disclosure at appointment.
- Institutional Investors (EQT, CPPIB, Bain) retain director nomination rights and certain committee seat rights, influencing board composition and governance dynamics.
- Ownership concentration: post-offering EQT ~19.3%, CPPIB ~14.8%, Bain ~10.8%; collective influence may affect governance outcomes.
Fixed Compensation
| Component | Amount/Terms | Notes |
|---|---|---|
| Annual cash retainer | $50,000 | Payable quarterly for non-employee directors not employed by Institutional Investors. |
| Committee chair retainers | Audit Chair: $25,000; Compensation Chair: $20,000; Nominating Chair: $15,000 | Payable quarterly. |
| Committee member retainers | Audit Member: $15,000; Compensation Member: $10,000; Nominating Member: $5,000 | Payable quarterly. |
| Non-executive Board Chair retainer | $100,000 | Additional cash retainer. |
| Deferral plan eligibility | Directors may defer cash and/or RSU settlement in 25% increments into Deferred Stock Units | Settlement can be at a future date, upon board departure, or earlier of both; one-time or up to 15 annual installments. |
Performance Compensation
| Equity Component | Grant Value | Vesting/Metrics | Notes |
|---|---|---|---|
| Annual equity retainer (RSUs) | ~$200,000 | Time-based vesting: RSUs granted at annual meeting, vest on first anniversary or before next annual meeting, subject to service | Applies to non-employee directors not employed by Institutional Investors. |
No director-specific performance metrics (e.g., TSR, EBITDA) are disclosed for non-employee director compensation; RSU vesting is time-based rather than performance-based.
Other Directorships & Interlocks
| Relationship | Detail | Governance Consideration |
|---|---|---|
| Employment at Google Cloud | Gupta is Global Director, Healthcare Solutions | Waystar publicly discusses a relationship with Google and embedding GenAI (AltitudeAI) across platform modules, creating a potential vendor interlock; company disclosed no Item 404 related-party transactions for Gupta at appointment. |
Expertise & Qualifications
- Deep AI strategy and digital transformation expertise applied to healthcare operations and access; led healthcare AI initiatives at Google Cloud.
- Extensive provider-side digital health experience (Kaiser Permanente).
- Board-level experience across public, private, and non-profit organizations (Neogen, Mölnlycke Health Care, HIMSS).
Equity Ownership
| Item | Detail | Date |
|---|---|---|
| Section 16 Power of Attorney (Form 3 authorization) | Filed by Aashima Gupta authorizing attorneys-in-fact for SEC filings related to Waystar securities | May 13, 2025 |
Beneficial ownership totals, vested/unvested equity, or options for Gupta were not disclosed in the available filings reviewed; Form 3 position details were not present in the document set.
Governance Assessment
- Strengths: Independent status and Audit & Risk Committee assignment bolster oversight; Gupta’s AI/healthcare technology expertise is aligned with Waystar’s strategic focus and platform evolution.
- Alignment: Director compensation structure blends modest cash retainers with annual RSU grants, with optional deferral into DSUs to encourage long-term alignment.
- Potential conflicts: Gupta’s senior role at Google Cloud coincides with Waystar’s public collaboration with Google on GenAI features (AltitudeAI); while no Item 404 transactions were disclosed at appointment, ongoing vigilance on vendor interlocks and recusal practices is prudent.
- Board dynamics risk: Sponsor nomination rights and concentrated ownership by EQT/CPPIB/Bain can shape board composition and committee seats, potentially affecting independence perceptions and investor confidence if not transparently managed.
RED FLAGS to monitor: Vendor interlock with Google Cloud given Gupta’s role (mitigated by current absence of related-party transactions); continued influence of Institutional Investors over board nominations and committees; ensure robust conflict management and disclosure protocols.